AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Cabergoline in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Gostinex Tablets_ Tablet | A4-101749 | Restore Healthcare Ltd | active | 25 Nov 2030 |
| Dostinex Tablets 0.5 mg** Tablet | B4-5542 | Pfizer Specialties Ltd | active | 29 Nov 2025 |
Cabergoline — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Cabergoline, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Cabergoline registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.